DGM
Darwin Global Management Portfolio holdings
AUM
$2.38B
This Quarter Return
+63.31%
1 Year Return
+81.43%
3 Year Return
+6,053.69%
5 Year Return
–
10 Year Return
–
AUM
$612M
AUM Growth
+$612M
(+67%)
Cap. Flow
+$53.5M
Cap. Flow
% of AUM
8.75%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
2
Closed
1
Top Buys
| 1 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$88.6M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$29.1M |
| 2 |
argenx
ARGX
|
$4.62M |
| 3 |
Keros Therapeutics
KROS
|
$1.34M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAM
1
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $275M | 44.91% | 16,688,636 +5,384,063 | +48% | +$88.6M |
|
|
2
TG Therapeutics
TGTX
$4.65B
| $230M | 37.68% | 9,278,439 -1,172,802 | -11% | -$29.1M |
|
|
3
argenx
ARGX
$43.6B
| $107M | 17.42% | 273,343 -11,855 | -4% | -$4.62M |
|
|
4
Keros Therapeutics
KROS
$618M
| – | – | -31,386 | Closed | -$1.34M |
|